← Start with Part 1: Course Drift
Part 5 of Navigation & Drift
Soundings and Unseen Hazards
The hidden hazards beneath stable systems.
Biotech teams spend a lot of time thinking about roadmaps, milestones, and visible risk.
But in complex adaptive systems, some of the most important constraints emerge long before they become obvious.
Checking your bearings and correcting course matter.
But at sea, the most dangerous hazards aren’t the storms you can see.
Even well-navigated ships face hazards that aren’t visible from the surface:
• latent constraints
• hidden dependencies
• delayed consequences
• structural weaknesses
• system dynamics that aren’t obvious in surface-level metrics
I see this often in biotech.
Teams focus on the roadmap, the data, and the next milestone.
But the system can appear stable until it suddenly isn’t.
That’s often where scale-up challenges, operational bottlenecks, infrastructure limitations, or organizational misalignment emerge.
Businesses are complex adaptive systems.
Problems rarely emerge as single isolated failures. Constraints interact. Small inefficiencies compound. Local optimizations create downstream consequences elsewhere in the system. And feedback is often delayed long enough that teams mistake temporary stability for resilience.
This can make biotech difficult to navigate. A process may work at bench scale but fail during scale-up. A technically successful platform may struggle commercially because the infrastructure can’t support it economically. An organization may appear aligned while operational drag quietly accumulates.
By the time these constraints become obvious, the cost of correction is often much higher than expected.
Captains took soundings because charts, weather, and visible conditions could only tell them so much. The most dangerous hazards were often the ones lurking beneath apparently navigable waters.
I think good R&D leadership works the same way.
Taking soundings in biotech means looking beyond topline milestones and asking:
• Where are the hidden constraints?
• Which assumptions have not been stress-tested?
• What dependencies could fail during scale-up?
• Where could operational drag accumulate?
• Which metrics are masking fragility rather than revealing resilience?
That’s why alignment reviews matter – not as backward-looking performance exercises, but as opportunities to reassess the system itself:
• priorities
• assumptions
• interdependencies
• resource allocation
• commercialization readiness
• and whether the current roadmap still reflects reality
Good leaders in biotech don’t just monitor progress. They probe for latent constraints. They stress-test assumptions before scale forces the issue. They recognize that stability and resilience are not the same thing.
They understand that navigation in complex adaptive systems is never static. Conditions change. Dependencies shift. Small inefficiencies compound over time.
That’s why staying on course requires more than vision.
It requires continual reassessment of the system itself.
In complex adaptive systems, preparedness matters more than certainty.
Next in Navigation & Drift →